-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
apoptosis, sickle cell disease, Bleeding and Clotting, cell division, Diseases, Biological Processes, Hemoglobinopathies, Thrombosis, Platelet Disorders, Clinically relevant, Thrombotic Disorders, inflammation, pathways, signal transduction
Monday, December 7, 2020: 7:00 AM-3:30 PM

Deirdre Nolfi-Donegan, MD1, Gowtham K Annarapu, PhD2, Cheryl A Hillery, MD1 and Sruti Shiva, PhD3,4,5*

1Pediatric Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA
2University of Pittsburgh, Pittsburgh, PA
3Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA
4Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA
5Center for Metabolism and Mitochondrial Medicine (C3M), University of Pittsburgh, Pittsburgh, PA

Adrienne Lee, MD1,2, Lorriane Chow, BSc, MD, FRCPC3*, Leslie Skeith, MD4, Joshua A Nicholas, BHSc, MD5*, Man-Chiu Poon, MD6, Alastair W. Poole, MA, PhD, VetMB7* and Ejaife O Agbani, PhD, BPharm, MSc8

1Department of Medicine, Cumming School of Medicine University of Calgary, Calgary, AB, Canada
2Southern Alberta Rare Blood & Bleeding Disorders Comprehensive Care Clinic, Calgary, AB, Canada
3Department of Anaesthesiology, Perioperative and Pain Medicine, University of Calgary, CALGARY, AB, Canada
4University of Calgary, Calgary, AB, Canada
5Department of Anesthesiology, Perioperative and Pain Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
6Division of Hematology, Department of Medicine, Foothills Hospital, University of Calgary, Calgary, AB, CAN
7School of Medical Sciences, University of Bristol, Bristol, GBR
8Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, CALGARY, AB, Canada

Rong Wei1,2*, Xiaojun Huang, MD1 and Bing Su2*

1Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China
2Shanghai Jiao Tong University School of Medicine, Shanghai, China

Jacqueline Adam, PhD1*, Thomas Gentinetta, PhD1*, Svetlana Diditchenko, PhD1*, Alexander Schaub, PhD1*, Gregory J Kato, MD2, Nathan Brinkman, PhD3* and Adrian Zuercher, PhD1*

1Research and Development, CSL Behring AG, Bern, Switzerland
2Clinical Research & Development, CSL Behring, King of Prussia
3Research & Development, CSL Behring, Kankakee, IL

Liang Li, PhD1*, Junyan Wang2*, Jieyu Ye, PhD2*, Liuming Yang3*, Beng H Chong, MBBS, PhD4,5 and Mo Yang1,3*

1The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
2Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
3Lianjiang People's Hospital, Lianjiang, China
4Medicine, University of New South Wales, Kogarah, Australia
5St George Hospital, Sydney, Australia

*signifies non-member of ASH